Research Topics
Species | Ian M GrahamSummaryAffiliation: The Adelaide and Meath Hospital Country: Ireland Publications
| Collaborators
|
Detail Information
Publications
Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of CardiologyIan M Graham
Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Dublin, Ireland
Eur J Cardiovasc Prev Rehabil 13:839-45. 2006..This survey examined barriers to implementing cardiovascular risk reduction guidelines...- European guidelines on cardiovascular disease prevention in clinical practice: executive summaryIan Graham
Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland
Atherosclerosis 194:1-45. 2007 - European guidelines on cardiovascular disease prevention in clinical practice: executive summaryIan Graham
Department of Cardiology, The Adelaide and Meath Hospital, Dublin, Ireland
Eur Heart J 28:2375-414. 2007 - European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representIan Graham
Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Dublin, Ireland
Eur J Cardiovasc Prev Rehabil 14:S1-113. 2007 - European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by rIan Graham
Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Doublin, Ireland
Eur J Cardiovasc Prev Rehabil 14:E1-40. 2007 - What impact will current trial data have on future guideline recommendations?Ian Graham
The Adelaide and Meath Hospital Dublin, Tallaght, Dublin, Ireland
Am J Med 118:42-7. 2005.... - The importance of total cardiovascular risk assessment in clinical practiceIan M Graham
Trinity College, Dublin, Ireland, Royal College of Surgeons, Dublin, Ireland
Eur J Gen Pract 12:148-55. 2006..The Third Joint European Guidelines on Cardiovascular Disease (CVD) Prevention highlight the importance of total cardiovascular risk prediction in planning preventive strategies... 
Assessment of cardiovascular riskMarie Therese Cooney
Department of Cardiology, Adelaide Meath Hospital, Tallaght, Dublin, 24, Ireland
Curr Hypertens Rep 12:384-93. 2010..systems estimate risk? What are the advantages and disadvantages of the current systems? What are the current limitations of risk estimation systems and how can they be resolved? What new developments have occurred in CVD risk estimation?..- Total cardiovascular disease risk assessment: a reviewMarie Therese Cooney
Department of Cardiology, Adelaide Meath Hospital, Tallaght, Dublin 24, Ireland
Curr Opin Cardiol 26:429-37. 2011..Here we review developments in the assessment and estimation of total CVD risk... - Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and womenMarie Therese Cooney
Department of Cardiology, Adelaide Meath Hospital, Tallaght, Dublin 24, Ireland
Am Heart J 159:612-619.e3. 2010..We aimed to clarify these inconsistencies... - Integrin α(IIb)β₃ exists in an activated state in subjects with elevated plasma homocysteine levelsSarah A McGarrigle
Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland
Platelets 22:65-73. 2011..These findings demonstrate that circulating Hcy can modulate the activation state of the platelet integrin α(IIb)β₃, a key player in platelet aggregation and thrombosis... - Value and limitations of existing scores for the assessment of cardiovascular risk: a review for cliniciansMarie Therese Cooney
Cardiology Department, Adelaide Meath Hospital, Tallaght, Dublin, Ireland
J Am Coll Cardiol 54:1209-27. 2009..But, it is likely that the widespread use of such an approach will help to address the issues of both undertreatment and overtreatment... - Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action ProjectRaymond Meleady
Department of Cardiology, Adelaide Meath Hospital, Incorporating the National Children s Hospital, Tallaght, Dublin, Ireland
Am J Clin Nutr 77:63-70. 2003..5.1.20) enzyme have elevated plasma concentrations of the cardiovascular disease risk factor homocysteine, particularly if folate depleted... - New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokersAnthony Fitzgerald
Department of Echocardiography, Royal Brompton Hospital, London, UK
Eur J Cardiovasc Prev Rehabil 12:542-7. 2005..Smoking cessation may profoundly reduce risk associated with other risk factors. We found no evidence of a relationship between activated factor XII and disease... - Guidelines on cardiovascular disease prevention in clinical practice: the European perspectiveIan M Graham
Epidemiology and Public Health Medicine, Royal College of Surgeons in Ireland, Dublin
Curr Opin Cardiol 20:430-9. 2005..To summarize the recommendations of the Third Joint European Society's Task Force on Cardiovascular Disease Prevention in Clinical Practice so that these may be made accessible to a wider audience... - Whither cardiovascular risk prediction?Ian M Graham
Eur J Cardiovasc Prev Rehabil 12:421-3. 2005 - Vitamins, homocysteine and cardiovascular riskIan M Graham
Royal College of Surgeons in Ireland; Trinity College Dublin, Ireland
Cardiovasc Drugs Ther 16:383-9. 2002..Thus meticulous risk factor control may be particularly important in subjects at high total cardiovascular risk who also have a raised plasma homocysteine level, and folic acid supplementation may be considered in such individuals...